WISCONSIN — The Medical College of Wisconsin (MCW) has joined a national effort that is researching and conducting trials on COVID-19 treatments for patients recovering at home.
The new clinical trial at MCW is focusing on the newest and most effective treatments for COVID-19, with a specific focus on those who are not hospitalized but are instead recovering at home.
The trial, called ACTIV-2, is funded by the National Institutes of Health and has study sites across the country. They will be testing patients who are not hospitalized but have tested positive within the past six days.
The Medical College of Wisconsin said this trial is meant to be very adaptive.
As new treatments for the disease are developed, ACTIV-2 patient participants will benefit. If a therapy appears effective, it can be advanced rapidly to testing in larger groups of volunteers, MCW said in a press release Tuesday.
At this time, the Medical College of Wisconsin is the only site in the state that is a part of this new trial.